| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 90810 | Null | 0.00578566967432518 | 0.35028827 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.00578566967432527 | 0.31331682 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.00578566967432527 | 0.18191152 |
| NSC 13484 | Null | 0.00578566967432527 | 0.16531885 |
| NSC 144163 | Quinoxaline, 6-chloro-2,3-bis(iodomethyl)- | 0.00578566967432527 | 0.33943699 |
| NSC 164970 | Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- | 0.00578566967432527 | 0.36285992 |
| NSC 58574 | Pyrimidine, 2,4,5-trichloro-6-propyl- | 0.00578566967432527 | 0.34388727 |
| NSC 601679 | Null | 0.00578566967432527 | 0.19506349 |
| NSC 603084 | 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (E)- | 0.00578566967432527 | 0.47612021 |
| NSC 623723 | Null | 0.00578566967432527 | 0.48863067 |